knowledge -WSS

knowledge

author：Wikipedia 2025-09-14 18:25:43 - browse：35513

When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart.

For more on what we cover, here’s where you can read Frank’s work; here’s more on Sarepta; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： WHO recommends second malaria vaccine

hotspot

WSS

'Brian's Song' at 50 still offers lessons about cancer for today

New oral drug delivery patch is modeled after octopus tentacles

IVG is promising — but it won’t replace IVF quite yet

It was time to plan for my old age. If only I could stop crying

Sweden knocks USA out of World Cup in penalty kicks

'Brian's Song' at 50 still offers lessons about cancer for today

entertainment

knowledge

focus

Duchenne breakthrough therapy leaves behind pioneering families

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

In age of alternative facts, a scholarly course on calling out crap

Kansas bar where gunfire wounded 9 last month closes permanently

Moonlake's readout produced a cash windfall. Risks remain

What will Novo Nordisk's VC do with its influx of cash?

Trump demands the U.S. pay no more for drugs than other countries … again

6 solutions to address cancer drug shortages and others

Walensky prepares to leave CDC — and Congress — behind

Study points to new risk in gene therapy death of Terry Horgan

hotspot

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

The biotech scorecard for Q4: 16 stock

It was time to plan for my old age. If only I could stop crying

Pennsylvania man bitten on the head by bear during attack in his garage

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

entertainment

focus

hotspot

explore